清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ellen完成签到 ,获得积分10
3秒前
HFH举报春风暮雪求助涉嫌违规
18秒前
cadcae完成签到,获得积分10
21秒前
拉长的诗蕊完成签到,获得积分10
37秒前
bkagyin应助Sshwcgd采纳,获得10
47秒前
HFH举报JoJo_Julie求助涉嫌违规
52秒前
自然亦凝完成签到,获得积分10
57秒前
蓝意完成签到,获得积分0
1分钟前
SAY完成签到 ,获得积分10
1分钟前
1分钟前
LL完成签到 ,获得积分10
1分钟前
玛卡巴卡爱吃饭完成签到 ,获得积分10
1分钟前
Lina完成签到,获得积分10
1分钟前
2分钟前
2分钟前
2分钟前
2分钟前
袁青寒发布了新的文献求助10
2分钟前
袁青寒发布了新的文献求助10
2分钟前
袁青寒发布了新的文献求助10
2分钟前
袁青寒发布了新的文献求助10
2分钟前
袁青寒发布了新的文献求助10
2分钟前
2分钟前
HFH举报justice0304求助涉嫌违规
2分钟前
Sshwcgd发布了新的文献求助10
2分钟前
newplexx完成签到,获得积分10
2分钟前
3分钟前
v0id应助科研通管家采纳,获得10
3分钟前
Sshwcgd完成签到,获得积分10
3分钟前
灿烂而孤独的八戒完成签到 ,获得积分0
3分钟前
3分钟前
Sshwcgd发布了新的文献求助10
3分钟前
3分钟前
思源应助Sshwcgd采纳,获得10
3分钟前
hitzwd完成签到,获得积分10
3分钟前
111完成签到 ,获得积分10
4分钟前
千里完成签到 ,获得积分10
4分钟前
4分钟前
Dongfang发布了新的文献求助10
4分钟前
俏皮夏瑶完成签到,获得积分10
4分钟前
高分求助中
Markov Chain Monte Carlo 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Common Foundations of American and East Asian Modernisation: From Alexander Hamilton to Junichero Koizumi 2000
Weaponeering: An Introduction Fourth Edition, Volume 1 1000
Advanced Weaponeering Fourth Edition, Volume 2 1000
Curating Socialism: A Handbook of International Art Exhibitions 1947-1989 750
悉尼大学博士学位论文,题目:Modelling and testing of one-sided stitched laminated composites. 作者:Kristopher P. Plain 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7521550
求助须知:如何正确求助?哪些是违规求助? 9108550
关于积分的说明 19447306
捐赠科研通 7125130
什么是DOI,文献DOI怎么找? 3254896
关于科研通互助平台的介绍 2423069
邀请新用户注册赠送积分活动 2241688